Fennec Pharmaceuticals (FENC) Former Director Raykov Rosty Sells Shares

What Happened
Raykov Rosty, a former director of Fennec Pharmaceuticals (FENC), sold 10,000 shares on August 3, 2026 at $9.58 per share, generating $95,800 in proceeds. The transaction is reported as a sale (S) and was executed pursuant to a pre-established trading plan.

Key Details

• Transaction date: 2026-08-03; Filing date (Form 4): 2026-08-04. No late filing indicated in the provided data.
• Price and amount: 10,000 shares at $9.58 per share; total proceeds $95,800.
• Transaction type: Sale (reported as open-market or private sale).
• Footnote: Sale executed pursuant to a 10b5-1 trading plan dated September 19, 2025.
• Shares owned after transaction: Not specified in the provided filing summary.

Context
Sales under a 10b5-1 plan are pre-scheduled trades and are commonly used to avoid timing-related issues; they do not necessarily reflect the insider’s current view of the company. For retail investors, purchases can be a stronger signal than routine sales; this single, modest sale (~$95.8K) should be viewed as procedural unless accompanied by other insider activity or material company news.